{"id":"W2921140763","doi":"10.1182/blood-2018-99-118148","title":"Efficacy and Safety of Ibrutinib (IBR) after Venetoclax (VEN) Treatment in IBR-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Follow-up of Patients from the MURANO Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Ven; Venetoclax; Medicine; Bendamustine; Rituximab; Ibrutinib; Internal medicine; Bristol-Myers; Neutropenia; Chronic lymphocytic leukemia; Oncology; Leukemia; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002643532,0.0004155862,0.0008379325,0.0001575182,0.00008801874,0.00001660513,0.0002820618,0.0001819917,0.0001578331],"category_scores_gemma":[0.0002569566,0.0002611551,0.0001190977,0.0004321388,0.000535833,0.0001251323,0.0002144012,0.0002100159,0.00002813423],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02621691,"about_ca_system_score_gemma":0.01412967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004825248,"about_ca_topic_score_gemma":0.001405187,"domain_scores_codex":[0.9967002,0.0002441077,0.0008530315,0.000673814,0.0009553087,0.0005735785],"domain_scores_gemma":[0.9973667,0.0005961732,0.0003318585,0.001149677,0.0003552534,0.0002003186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02975862,0.005135495,0.9454856,0.0002258333,0.001484784,0.0000945013,0.007985647,0.00002975494,0.0002779944,0.000002833587,0.00009276609,0.009426156],"study_design_scores_gemma":[0.2666784,0.01027212,0.719245,0.0005159901,0.0006213596,0.000003018715,0.0001818086,0.0001995322,0.001751744,0.000004290236,0.0003313278,0.0001954853],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951835,0.0008211182,0.000001535407,0.000008216757,0.00017163,0.003366915,0.0001450736,0.00002686074,0.0002751067],"genre_scores_gemma":[0.9990761,0.0001020713,0.00006348811,0.00003441013,0.0001807871,0.0001545661,0.0001167494,0.00007227203,0.0001995841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2369198,"threshold_uncertainty_score":0.9999841,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01054866114697365,"score_gpt":0.2510935840606621,"score_spread":0.2405449229136885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}